Severe Heart Failure Clinical Trial
Official title:
Comparison of Patient Care Management Strategies of Heart Failure in the Rhône-Alpes Region. A Clinical and Economic Study.
The heart failure is a chronic pathology with prevalence from 2 to 3% of general population,
a death rate of 50% at 6 months for patients with stage IV, and a probability of death or
hospitalization or emergency consultation of 40% at 3 years. The care of patients is
heterogeneous, especially in light of the organization of therapeutic education offered to
patients and patient monitoring modalities.
The aim of this study is to investigate the management strategies for patients with chronic
heart failure stage III or IV NYHA, and heart failure patients with stage II NYHA with
previous hospitalization for heart failure.
This is a longitudinal observational multicenter study comparing a management strategy
including patient education and monitoring as part of a hospital dedicated organization and
an organization of care as usually done in France.
The primary endpoint was a composite endpoint of morbidity and mortality involving deaths,
unplanned readmissions and emergency visits for heart failure.
The expected number of patients is 720 patients (360 per strategy). The follow-up duration of
24 months.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03062241 -
Ablation of Atrial Fibrillation in Heart Failure Patients
|
N/A |